Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon

Breast cancer is the most prevalent malignancy in women in Western countries, currently accounting for one third of all female cancers. Familial aggregation is thought to account for 5–10 % of all BC cases, and germline mutations in BRCA1 and BRCA2 account for less of the half of these inherited cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalkh, Nadine, Nassar-Slaba, Jinane, Chouery, Eliane, Salem, Nabiha, Uhrchammer, Nancy, Golmard, Lisa, Stoppa-Lyonnet, Domique, Bignon, Yves-Jean, Mégarbané, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441239/
https://www.ncbi.nlm.nih.gov/pubmed/22713736
http://dx.doi.org/10.1186/1897-4287-10-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441239/
https://www.ncbi.nlm.nih.gov/pubmed/22713736
http://dx.doi.org/10.1186/1897-4287-10-7

Ejemplares similares